Literature DB >> 23151044

Acute traumatic brain injury: is current management evidence based? An empirical analysis of systematic reviews.

Jin Lei1, Guoyi Gao, Jiyao Jiang.   

Abstract

Traumatic brain injury (TBI) is a major health and socioeconomic problem worldwide with a high rate of death and long-term disability. Previous studies have summarized evidence from large-scale randomized trials, finding no intervention showing convincing efficacy for acute TBI management. The present empirical study set out to assess another crucial component of evidence base-systematic review, which contributes a lot to evidence-based health care, in terms of clinical issues, methodological aspects, and implication for practice and research. A total of 44 systematic reviews pertaining to therapeutic interventions for acute TBI were identified through electronic database searching, clinical guideline retrieval, and expert consultation, of which 21 were published in Cochrane Library and 23 in peer-reviewed journals. Their methodological quality was generally satisfactory, with the median Overview Quality Assessment Questionnaire score of 5.5 (interquartile range 2-7). Cochrane reviews are of better quality than regular journal reviews. Twenty-nine high-quality reviews provided no conclusive evidence for the investigated 22 interventions except for an adverse effect of corticosteroids. Less than one-third of the component trials were reported with adequate allocation concealment. Additionally other methodological flaws in design-for example, ignoring heterogeneity among the TBI population-also contributed to the failure of past clinical research. Based on the above findings, evidence from both systematic reviews and clinical trials does not fully support current management of acute TBI. Translating from laboratory success to clinical effect remains an unique challenge. Accordingly it may be the time to rethink the way in future practice and clinical research in TBI.

Entities:  

Mesh:

Year:  2013        PMID: 23151044     DOI: 10.1089/neu.2012.2548

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  7 in total

Review 1.  Investigational agents for treatment of traumatic brain injury.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Investig Drugs       Date:  2015-03-01       Impact factor: 6.206

2.  Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury.

Authors:  Yanlu Zhang; Michael Chopp; Yuling Meng; Mark Katakowski; Hongqi Xin; Asim Mahmood; Ye Xiong
Journal:  J Neurosurg       Date:  2015-01-16       Impact factor: 5.115

3.  What's new in emergencies, trauma, and shock? Heparin in severe traumatic brain injury: Beyond venous thromboembolism prevention?

Authors:  Luca Masotti; Mario Di Napoli; Daniel Agustin Godoy; Gianni Lorenzini
Journal:  J Emerg Trauma Shock       Date:  2014-07

4.  Hydroxysafflor yellow A exerts antioxidant effects in a rat model of traumatic brain injury.

Authors:  Yang Wang; Chunhu Zhang; Weijun Peng; Zian Xia; Pingping Gan; Wei Huang; Yafei Shi; Rong Fan
Journal:  Mol Med Rep       Date:  2016-09-06       Impact factor: 2.952

5.  Levels of lncRNA GAS5 in Plasma of Patients with Severe Traumatic Brain Injury: Correlation with Systemic Inflammation and Early Outcome.

Authors:  Jin Lei; Xiao Zhang; Rui Tan; Yu Li; Kai Zhao; Hongquan Niu
Journal:  J Clin Med       Date:  2022-06-09       Impact factor: 4.964

6.  Glial fibrillary acidic protein as a biomarker in severe traumatic brain injury patients: a prospective cohort study.

Authors:  Jin Lei; Guoyi Gao; Junfeng Feng; Yichao Jin; Chuanfang Wang; Qing Mao; Jiyao Jiang
Journal:  Crit Care       Date:  2015-10-12       Impact factor: 9.097

Review 7.  Current understanding of neuroinflammation after traumatic brain injury and cell-based therapeutic opportunities.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Chin J Traumatol       Date:  2018-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.